Ten government agencies jointly issued China's pharmaceutical industry roadmap for 2026–2030, setting a 20% annual growth target for innovative drugs and aiming for China to account for 25% or more of global first-in-class new drug approvals by 2030.
From $9/month · 7-day free trial
Already a subscriber? Log in
Subscribe for full access to all articles
Start Free Trial
Washington is shifting export control pressure from hardware to cloud access, threatening the workaround Chinese AI developers have relied on for years.
Hangzhou, one of China's leading tech hubs, has opened a public consultation on scrapping its dedicated financial support package for the low-altitude economy sector — the first Chinese city to propose such a repeal. The package offered up to 200 million yuan for anchor enterprises.
Six military figures have been removed from China's national parliament, the latest episode in Xi Jinping's ongoing purge of the defence establishment. NPC membership carries formal political legitimacy, making removal a public act of disgrace rather than a routine administrative change.